On the path of assisted reproduction, 46 years old is a challenging number. When patients in this age group only obtain one poor quality, unusable egg after a single ovulation induction, many may feel hopeless and believe that this is the end of their reproductive journey.
But today, at the Tulip International Reproductive Center, we want to share a true story. It was only after such a difficult start that this story finally saw a real turning point. It concerns science, timing, and more importantly, a determination to break conventions and strive for the greatest possible outcome for life.
Q1: What is the core difficulty of IVF treatment for a 46 year old woman?
A: For ultra elderly women aged 46 and above, the core challenges mainly focus on two aspects:
Sudden decline in ovarian reserve function (DOR): This means that the number of remaining basal follicles in the ovary is very rare. Therefore, under conventional ovulation induction protocols, there are often only one or two follicles that can be "awakened" and grow, or even none.
The problem of egg quality is prominent: as age increases, the probability of chromosomal abnormalities (aneuploidy) occurring in eggs increases exponentially. Over 80% -90% of eggs aged 45 and above may have chromosomal abnormalities. That's why even if one is lucky enough to retrieve an egg, they often encounter difficulties such as unfertilized, abnormally fertilized, or embryos that cannot pass genetic screening (PGT).
Therefore, when a 46 year old patient only obtains one abnormal egg in one cycle, it is not only a true reflection of the difficulty of reproduction at an advanced age, but also a huge test of the confidence of the patient and the doctor.
Q2: How did the turning point of the story occur after this seemingly 'failed' cycle?
A: This is precisely the core of the case we are going to share today. The protagonist is Ms. W, 46 years old. Her first ovulation induction cycle at the Tulip International Reproductive Center did not yield satisfactory results, as she only retrieved an egg that had not been fertilized properly.
However, the turning point occurred on the day of the egg retrieval surgery.
In the routine ultrasound examination after egg retrieval, our attending expert keenly discovered three newly "protruding" small antral follicles in Ms. W's ovaries, with diameters ranging from 6mm to 9mm. In the routine procedure, doctors will advise patients to wait for the next menstrual cycle before evaluating whether to enter a new cycle. But our expert team immediately realized that this was a fleeting and valuable opportunity.
The team quickly communicated and reached a consensus within a few minutes: no waiting! Start the second 'back-to-back' promotion cycle immediately!
Q3: What is "back-to-back" ovulation induction (luteal phase ovulation induction)? Why dare to make this decision on the day of egg retrieval?
A: The more accurate medical term for "back-to-back" ovulation induction is Luteal Phase Stimulation.
Conventional ovulation induction: usually begins during the follicular phase after menstruation in women, using medication to promote synchronous growth of a batch of follicles.
Luteal ovulation induction: refers to the process of inducing ovulation immediately during the luteal phase, without waiting for menstruation, by utilizing a new batch of antral follicles that have appeared in the ovary.
The confidence in making this decision stems from the profound understanding of the endocrine laws of elderly women by the expert team of Tulip International Reproductive Center. We know that after egg retrieval, the body is in a high progesterone "luteal phase" environment, which usually inhibits the brain from secreting new follicle stimulating hormone (FSH), which is not conducive to follicle growth. But through precise drug intervention, we can cleverly transform this' unfavorable 'environment into a' golden starting point 'for the next cycle.
Q4: How does the specific medication plan "turn the tide"? What is its scientific logic?
A: The luteal phase ovulation promotion plan we developed for Ms. W can be regarded as a sophisticated "combination punch", with the core logic of "internal and external considerations, coordinated activation".
Step 1: Use "Letrozole" to awaken endogenous power.
Mechanism of action: Letrozole is an aromatase inhibitor that can prevent the conversion of testosterone to estrogen in the body. When the body perceives that estrogen levels have been artificially lowered, a signal of "estrogen deficiency" is generated and fed back to the brain (pituitary gland). To correct this' illusion ', the brain will order the secretion of more of its own FSH in an attempt to' save 'the ovaries. This endogenous FSH serves as a mild "activation signal" to awaken the newly discovered small follicles.
Step 2: Supplement Menopur with exogenous fuel.
Mechanism of action: While the brain is successfully "awakened" to mobilize its own potential, we provide exogenous "fuel" directly for follicle growth by injecting small doses of Minolta. Mino pregnancy contains both FSH and luteinizing hormone (LH) components, which can more comprehensively support the development and maturation of follicles.
The essence of this plan is that we did not forcefully combat the high progesterone environment during the luteal phase, but cleverly used drugs to bypass its inhibitory effect. By "deceiving" the brain and supplementing external aid through a dual pathway, we successfully seamlessly integrated a cycle that originally needed rest into an efficient continuous ovulation cycle.
Q5: What is the final outcome of this' back-to-back 'plan?
A: Ms. W's experience perfectly validates the effectiveness of this cutting-edge strategy.
The previous cycle (conventional follicular phase stimulation) resulted in one abnormal egg.
The following cycle (luteal phase immediately promotes ovulation): After only 5 days of medication, ultrasound follow-up showed that the ovarian response far exceeded the previous cycle. The three small follicles I saw earlier have grown vigorously, with sizes reaching 16mm, 15mm, and 13mm respectively.
In the end, during this' back-to-back 'cycle, we successfully retrieved 2 valuable mature eggs (MII) for Ms. W.
Ms. W obtained 2 high-quality mature eggs in less than a week from particle failure. This result is not only a breakthrough in quantity, but also a path to accumulating high-quality embryos for her, bringing substantial progress and tremendous confidence.
Behind the strategy lies the support of a professional system
The ability to decisively and efficiently implement a high-level personalized program such as "luteal phase ovulation promotion" for Ms. W is not accidental, it relies on the strong support of the entire medical system of Tulip International Reproductive Center:
Profound clinical insights: Our expert team has conducted in-depth research on the endocrine characteristics of elderly and low ovarian response (DOR) patients, daring to break conventional thinking and strive for every possible opportunity for patients.
Seamless team collaboration: Clinical doctors and embryo laboratories seamlessly connect 24/7 to ensure real-time information synchronization, make quick decisions together, and never miss any valuable treatment window.
Patient oriented flexible system: We adhere to individualized treatment and can initiate cycles based on your ovarian response at any time, rather than letting you adapt to a fixed hospital schedule.
At the Tulip International Fertility Center, we firmly believe that addressing the challenges of extremely old age reproduction requires not just empty talk of miracles, but a deep understanding of life sciences, scientifically rigorous strategies, excellent laboratory technology, and a sense of responsibility to seize every minute. Our original intention is to hope that every family that chooses us can soon realize their dream of becoming parents.
For fertility consultation in Kyrgyzstan, please contact your dedicated consultant
/Fertility Consultation /
Dr.Chan
Copy and add: Tulip_EnoChan
Or long press/scan the QR code to add
Tulip International Fertility Center
Technology aids fertility, fulfilling dreams for countless families
